Update on systemic treatment in early triple negative breast cancer

Triple negative breast cancer (TNBC) is a heterogeneous disease representing about 15% of all breast cancers. TNBC are usually high-grade histological tumors, and are generally more aggressive and difficult to treat due to the lack of targeted therapies available, and chemotherapy remains the standa...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ther Adv Med Oncol
Main Authors: Núñez Abad, Martín, Calabuig-Fariñas, Silvia, Lobo de Mena, Miriam, José Godes Sanz de Bremond, María, García González, Clara, Torres Martínez, Susana, García-García, José Ángel, Iranzo González-Cruz, Vega, Camps Herrero, Carlos
Formato: Artigo
Idioma:Inglês
Publicado em: SAGE Publications 2021
Assuntos:
Review
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7871289/
https://ncbi.nlm.nih.gov/pubmed/33613695
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758835920986749
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados